These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 2845080)

  • 1. The binding of native DNA to the collagen-like segment of Clq.
    Rosenberg AM; Prokopchuk PA; Lee JS
    J Rheumatol; 1988 Jul; 15(7):1091-6. PubMed ID: 2845080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The binding of dsDNA and ssDNA to human types I, II and IV collagens.
    Rosenberg AM; Prokopchuk PA
    J Rheumatol; 1986 Jun; 13(3):512-6. PubMed ID: 3488402
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The binding and activation of the Clr-Cls subunit of the first component of human complement.
    Hughes-Jones NC; Gorick BD
    Mol Immunol; 1982 Sep; 19(9):1105-12. PubMed ID: 6292705
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The location of binding sites on C1q for DNA.
    Uwatoko S; Mannik M
    J Immunol; 1990 May; 144(9):3484-8. PubMed ID: 2329279
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin interacts with Clq, a subcomponent of the first component of complement.
    Isliker H; Bing DH; Lahan J; Hynes RO
    Immunol Lett; 1982 Jan; 4(1):39-43. PubMed ID: 6277780
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The binding of DNA to native type II collagen.
    Rosenberg AM; Hunt DW; Petty RE
    J Rheumatol; 1983 Dec; 10(6):925-9. PubMed ID: 6663596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serial analysis of autoantibody responses to the collagen-like region of Clq, collagen type II, and double stranded DNA in patients with systemic lupus erythematosus.
    Sjoholm AG; Martensson U; Sturfelt G
    J Rheumatol; 1997 May; 24(5):871-8. PubMed ID: 9150075
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The interaction of human plasma fibronectin with a subunit of the first component of complement, C1q.
    Pearlstein E; Sorvillo J; Gigli I
    J Immunol; 1982 May; 128(5):2036-9. PubMed ID: 6801128
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Kinetics of activation of the first component of complement (C1) by IgG oligomers.
    Tschopp J
    Mol Immunol; 1982 May; 19(5):651-7. PubMed ID: 6287242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-molecular weight C1q-binding immunoglobulin G in patients with systemic lupus erythematosus consists of autoantibodies to the collagen-like region of C1q.
    Uwatoko S; Mannik M
    J Clin Invest; 1988 Sep; 82(3):816-24. PubMed ID: 3262124
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interaction between fibronectin and C1q in rheumatoid synovial fluid and normal plasma.
    Carsons SE; Schwartzman S; Diamond HS; Berkowitz E
    Clin Exp Immunol; 1988 Apr; 72(1):37-42. PubMed ID: 3135129
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A key role for fibronectin in the sequential binding of native dsDNA and monoclonal anti-DNA antibodies to components of the extracellular matrix: its possible significance in glomerulonephritis.
    Lake RA; Morgan A; Henderson B; Staines NA
    Immunology; 1985 Feb; 54(2):389-95. PubMed ID: 3871423
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction of C1q with beta 2-microglobulin.
    Björck L; Johnson U; Sjöholm AG
    Acta Pathol Microbiol Immunol Scand Suppl; 1984; 284():19-23. PubMed ID: 6375255
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of the first component of human complement, C1, by monoclonal antibodies directed against different domains of subcomponent C1q.
    Kilchherr E; Schumaker VN; Phillips ML; Curtiss LK
    J Immunol; 1986 Jul; 137(1):255-62. PubMed ID: 3486914
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The binding site for C1q on IgG.
    Duncan AR; Winter G
    Nature; 1988 Apr; 332(6166):738-40. PubMed ID: 3258649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complement fixation by solid phase immune complexes. Reduced capacity in SLE sera.
    Baatrup G; Jonsson H; Sjöholm A; Sturfelt G; Svehag SE
    J Clin Lab Immunol; 1988 Jun; 26(2):73-9. PubMed ID: 3264027
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antibody-independent C1 activation by E. coli.
    Tenner AJ; Ziccardi RJ; Cooper NR
    J Immunol; 1984 Aug; 133(2):886-91. PubMed ID: 6376630
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal anti-mouse macrophage antibodies recognize the globular portions of C1q, a subcomponent of the first component of complement.
    Heinz HP; Dlugonska H; Rüde E; Loos M
    J Immunol; 1984 Jul; 133(1):400-4. PubMed ID: 6609989
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is alpha-actinin a target for pathogenic anti-DNA antibodies in lupus nephritis?
    Mason LJ; Ravirajan CT; Rahman A; Putterman C; Isenberg DA
    Arthritis Rheum; 2004 Mar; 50(3):866-70. PubMed ID: 15022329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activator-bound C1 is less susceptible to inactivation by C1 inhibition than is fluid-phase C1.
    Tenner AJ; Frank MM
    J Immunol; 1986 Jul; 137(2):625-30. PubMed ID: 3722818
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.